CVS Health (CVS) Stock Price, News & Analysis

CVS Health logo
$54.20 -1.49 (-2.67%)
Closing price 03:59 PM Eastern
Extended Trading
$54.36 +0.15 (+0.28%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CVS Health Stock (NYSE:CVS)

Key Stats

Today's Range
$53.84
$55.98
50-Day Range
$43.78
$59.96
52-Week Range
$43.56
$80.75
Volume
14.97 million shs
Average Volume
12.78 million shs
Market Capitalization
$68.21 billion
P/E Ratio
13.76
Dividend Yield
4.91%
Price Target
$68.12
Consensus Rating
Moderate Buy

Company Overview

CVS Health Corporation, founded in 1963 by Stanley Goldstein, Sidney Goldstein and Ralph Hoagland, began as Melville, a health and beauty aid store chain in Lowell, Massachusetts. 

In 1996, CVS Corporation spun off from Melville and became a standalone company trading as CVS on the New York Stock Exchange. Today, CVS Health Corporation is a leading American healthcare company that owns CVS Pharmacy, CVS Caremark and Aetna.

CVS Health Corp offers its customers a range of health solutions. It operates through three main segments: healthcare benefits, pharmacy services and retail. The Health Care Benefits segment provides various traditional, voluntary and consumer-directed health insurance products to different groups, including individuals, employer groups, college students, health care providers and governmental units. 

The pharmacy services segment offers a range of pharmacy benefit management solutions, including plan design and administration, clinical, formulary management, retail pharmacy network management, specialty pharmacy and infusion and medical spend management services. This segment serves insurance companies, prescription drug plans, health plans, unions, employers, Medicaid-managed care plans and individuals. 

The retail segment sells prescription and over-the-counter drugs, personal care products and consumer health and beauty products. It also provides health care services through MinuteClinic walk-in medical clinics. It distributes prescription drugs while offering pharmacy consulting and other ancillary services to care facilities and different care settings. Additionally, it operates specialty mail-order, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services.

CVS Health Corporation is one of the largest healthcare providers in the United States. In 2021, it ranked fourth on the Fortune 500 list and seventh on the Fortune Global 500 list. 

The company faced criticism in November 2021 when a federal jury found that CVS, Walgreens and Walmart "had substantially contributed to" the opioid crisis. Despite this setback, CVS Health Corp remains dedicated to its broader healthcare commitment, as reflected by its decision to change its corporate name to CVS Health in September 2014. In February 2020, CVS Health announced changes to its board of directors, reducing the size from 16 to 13 directors.

In December 2017, CVS Health Corp agreed to acquire Aetna for $69 billion, completing the acquisition in November 2018. The purchase of Aetna, a leading health insurance company, allowed CVS Health Corp to expand its services to a broader range of customers. 

CVS Health Corp's success is also due to its subsidiary, Caremark, established in 1979 by James M. Sweeney as Home Health Care of America (HHCA), which later changed its name to Caremark in 1985. In 1996, Caremark merged with MedPartners/Mullikin Inc., the combined company called MedPartners Inc. In 1998, MedPartners changed its name to Caremark Rx. Caremark was fined $160 million in 1991 for a "four-year-long federal mail-fraud and kickback" scheme in which it "paid doctors to steer patients to its intravenous drug service."

On November 18, 2021, CVS Health announced plans to close 900 stores over the next three years, with closing beginning in the spring of 2022. The company's decision to close stores could result from increased competition in the healthcare industry, changing consumer behavior and the COVID-19 pandemic. The company is confident in its ability to continue to provide quality healthcare services to customers.

CVS Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
100th Percentile Overall Score

CVS MarketRank™: 

CVS Health scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 217 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 14 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CVS Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CVS Health's stock forecast and price target.
  • Earnings Growth

    Earnings for CVS Health are expected to grow by 14.79% in the coming year, from $5.14 to $5.90 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CVS Health is 13.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CVS Health is 13.76, which means that it is trading at a less expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 124.35.

  • Price to Earnings Growth Ratio

    CVS Health has a PEG Ratio of 0.62. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    CVS Health has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about CVS Health's valuation and earnings.
  • Percentage of Shares Shorted

    1.35% of the float of CVS Health has been sold short.
  • Short Interest Ratio / Days to Cover

    CVS Health has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CVS Health has recently decreased by 6.13%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    CVS Health is a leading dividend payer. It pays a dividend yield of 4.71%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    CVS Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CVS Health is 67.51%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CVS Health will have a dividend payout ratio of 45.08% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

  • Read more about CVS Health's dividend.
  • Percentage of Shares Shorted

    1.35% of the float of CVS Health has been sold short.
  • Short Interest Ratio / Days to Cover

    CVS Health has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CVS Health has recently decreased by 6.13%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CVS Health has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Retail/Wholesale companies.
  • News Coverage This Week

    MarketBeat has tracked 53 news articles for CVS Health this week, compared to 30 articles on an average week.
  • Search Interest

    Only 123 people have searched for CVS on MarketBeat in the last 30 days. This is a decrease of -15% compared to the previous 30 days.
  • MarketBeat Follows

    75 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is an increase of 97% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CVS Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.24% of the stock of CVS Health is held by insiders.

  • Percentage Held by Institutions

    80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CVS Health's insider trading history.
Receive CVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

CVS Stock News Headlines

Cigna Close-up of a tablet pc with a digital screen. — Photo by Wirestock
Cigna Misses EPS: What It Means for the Health Insurance Industry (CVS)
Cigna is one of the most efficiently managed health insurance companies evidenced by its foresight to sell its Medicare Advantage business before the fallout.
KONSKIE, POLAND - June 11, 2019: Teva Pharmaceutical Industries Ltd company logo on mobile phone — Stock Editorial Photography
Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now (CVS)
Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?
Elon’s ‘Agents’ Strike
He might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that could ultimately define his legacy, Elon is now a "special government employee". And his first decision in the role could have dramatic consequences for you and hundreds of millions of Americans.
Healthcare stock momentum
Momentum Grows for These 3 Healthcare Stocks (CVS)
As the market starts to reflect on the potential tail risks in the S&P 500, a rotation has shown itself in three stocks in the healthcare sector.
A bag of money with the word dividends written on it, on a dollar background.
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
Amid rising market uncertainty and rate concerns, high-yield dividend stocks offer a blend of income and stability for cautious investors.
CVS Health and Duquesne team up to tackle pharmacist shortage
See More Headlines

CVS Stock Analysis - Frequently Asked Questions

CVS Health's stock was trading at $44.89 on January 1st, 2025. Since then, CVS shares have increased by 20.7% and is now trading at $54.2020.
View the best growth stocks for 2025 here
.

CVS Health Co. (NYSE:CVS) posted its earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. CVS Health's revenue for the quarter was up 6.3% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of CVS Health: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and more.

CVS Health's top institutional shareholders include Charles Schwab Investment Management Inc. (1.03%), Bank of New York Mellon Corp (0.70%), Nordea Investment Management AB (0.41%) and State of Michigan Retirement System (0.28%). Insiders that own company stock include Thomas M Moriarty, Karen S Lynch, Alan Lotvin, Prem S Shah, Edward J Ludwig, James David Clark and Daniel P Finke.
View institutional ownership trends
.

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Meta Platforms (META), Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Advanced Micro Devices (AMD), Chevron (CVX) and Tesla (TSLA).

Company Calendar

Last Earnings
11/06/2024
Ex-Dividend for 2/3 Dividend
1/23/2025
Dividend Payable
2/03/2025
Today
2/06/2025
Next Earnings (Estimated)
2/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
12665010
Employees
300,000
Year Founded
1963

Price Target and Rating

Average Stock Price Target
$68.12
High Stock Price Target
$86.00
Low Stock Price Target
$58.00
Potential Upside/Downside
+25.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
20 Analysts

Profitability

Net Income
$8.34 billion
Pretax Margin
1.82%

Debt

Sales & Book Value

Annual Sales
$357.78 billion
Cash Flow
$11.66 per share
Book Value
$59.55 per share

Miscellaneous

Outstanding Shares
1,258,410,000
Free Float
1,255,388,000
Market Cap
$68.21 billion
Optionable
Optionable
Beta
0.61

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:CVS) was last updated on 2/6/2025 by MarketBeat.com Staff
From Our Partners